T1	Disorder 9 32	Graves' hyperthyroidism
T2	Disorder 53 67	thyrotoxicosis
N1 	Reference T2 UMLS:C0040156	thyrotoxicosis
T3	Pharmacological_substance 75 85	interferon
N1000 	Reference T3 MeSH:D007372	interferon
T4	Disorder 98 122	chronic hepatitis type C
N2 	Reference T4 UMLS:C0524910	chronic hepatitis type C
T5	Disorder 145 168	Graves' hyperthyroidism
T6	Pharmacological_substance 190 200	interferon
N1001 	Reference T6 MeSH:D007372	interferon
T7	Disorder 250 281	chronic active hepatitis type C
N3 	Reference T7 UMLS:C0019158	chronic active hepatitis type C
T8	Pharmacological_substance 335 344	IFN-alpha
N1002 	Reference T8 MeSH:D016898	IFN-alpha
T10	Disorder 414 428	thyrotoxicosis
N4 	Reference T10 UMLS:C0040156	thyrotoxicosis
T11	Pharmacological_substance 464 467	IFN
N1003 	Reference T11 MeSH:D007372	IFN
T14	Disorder 545 568	Graves' hyperthyroidism
T15	Disorder 627 641	thyrotoxicosis
N5 	Reference T15 UMLS:C0040156	thyrotoxicosis
T19	Disorder 719 742	Graves' hyperthyroidism
T20	Pharmacological_substance 750 753	IFN
N1004 	Reference T20 MeSH:D007372	IFN
T21	Disorder 856 871	hyperthyroidism
N6 	Reference T21 UMLS:C0020550	hyperthyroidism
T23	Pharmacological_substance 201 205	(IFN
N1005 	Reference T23 MeSH:D007372	(IFN
T22	Subject 218 235	52-year-old woman
